Company news
Neural Therapeutics Inc. (CSE:NURL) news
Neural Therapeutics Inc. news releases on 6ix. Latest, Aug 14, 2026: Hanf.com Transaction Advances as Neural Therapeutics Receives CSE Conditional Approval
Press releases & updates
Hanf.com Transaction Advances as Neural Therapeutics Receives CSE Conditional Approval
August 14, 2026
Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reporting
June 19, 2026
Neural Therapeutics Announces AGSM Results, CFO Appointment and Welcomes Positive Developments in the German Cannabis Market
June 12, 2026
Neural Therapeutics Announces Filing and Mailing of Meeting Materials for Annual and Special Meeting to Approve Series B Transactions with CWE
May 1, 2026
Neural Therapeutics Announces Amendment to SIO Agreement, Concurrent Financing Terms, Shareholder Meeting Date and RSU Grant
March 27, 2026
Neural Therapeutics Announces CSE Application to Acquire Full Ownership of Hanf.com, Shareholder Meeting, SIO Agreement Amendment and Concurrent Financing
February 19, 2026
Neural Portfolio Company Hanf.com Reports Strong Fiscal 2025 Results with 58% Revenue Growth and Positive Normalized Operating Income
February 10, 2026
Neural's Portfolio Company Hanf.com Announces Sales Start of Ritual Herbs Nicotine and Tobacco Free Products
January 27, 2026
Neural's Portfolio Company Hanf.com Expands Retail Footprint to Northern Germany with Two New Stores in Bielefeld and Herford
November 6, 2025
Neural Portfolio Company Hanf.com Reports Strong Fiscal 2024 Results with 65% Revenue Growth, Positive Cash Flow and Double-Digit Operating Margin; Continued Growth in 2025; First Half Revenues Up 31% Year-Over-Year
October 8, 2025
Neural's Partner Hanf.com Expands Retail Footprint with 17th Store Opening Near Munich
September 23, 2025
Neural Announces Completion of the Acquisition of a 30.75% Interest in Hanf.com, a Profitable German CBD Retail Store Chain
August 13, 2025
Neural Announces Approval of the Strategic Investment and Option Agreement by CWE Shareholders to Acquire up to 100% of CWE
July 22, 2025
Neural Advances Ethnobotanical Strategy Through Execution of SERFOR Research Agreement and CWE's Exclusive German Distribution Agreement with Ritual Herbs
July 21, 2025
Neural's Partner CWE to Open Store No. 16 in the City of Bonn and Invitation to Meet Hanf.com at Mary Jane Berlin 2025
June 6, 2025
Neural Therapeutics and Hanf.com Sign Strategic Investment and Option Agreement to Create a Science-Backed Botanical Wellness Leader
May 28, 2025
Neural Therapeutics Announces RSU and Options Grant
May 13, 2025
Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM
May 9, 2025
Neural Therapeutics Strengthens IP Portfolio With a Patent Application
April 14, 2025
Neural Therapeutics Commences Trading on Frankfurt Stock Exchange
March 31, 2025
Canadian Securities Exchange Welcomes Listing of Neural Therapeutics Inc.
March 17, 2025
Neural Therapeutics Commences Trading, Provides Update on Growth Initiatives and Engages Investor Relations Consultants
March 17, 2025